[go: up one dir, main page]

NO20014221L - Fremgangsmåte for behandling av anstrengelses-indusert astma - Google Patents

Fremgangsmåte for behandling av anstrengelses-indusert astma

Info

Publication number
NO20014221L
NO20014221L NO20014221A NO20014221A NO20014221L NO 20014221 L NO20014221 L NO 20014221L NO 20014221 A NO20014221 A NO 20014221A NO 20014221 A NO20014221 A NO 20014221A NO 20014221 L NO20014221 L NO 20014221L
Authority
NO
Norway
Prior art keywords
exertion
treating
induced asthma
asthma
induced
Prior art date
Application number
NO20014221A
Other languages
English (en)
Other versions
NO20014221D0 (no
Inventor
Richard Nieman
Theodore Torphy
Siegfried Christensen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20014221D0 publication Critical patent/NO20014221D0/no
Publication of NO20014221L publication Critical patent/NO20014221L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Fremgangsmåter for behandling av anstrengelses-indusert astma ved an-vendelse av en PDE 4-inhibitor er beskrevet.
NO20014221A 1999-03-01 2001-08-31 Fremgangsmåte for behandling av anstrengelses-indusert astma NO20014221L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12246499P 1999-03-01 1999-03-01
US14129199P 1999-06-28 1999-06-28
PCT/US2000/005363 WO2000051599A1 (en) 1999-03-01 2000-03-01 Method for treating exercise induced asthma

Publications (2)

Publication Number Publication Date
NO20014221D0 NO20014221D0 (no) 2001-08-31
NO20014221L true NO20014221L (no) 2001-10-24

Family

ID=26820540

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014221A NO20014221L (no) 1999-03-01 2001-08-31 Fremgangsmåte for behandling av anstrengelses-indusert astma

Country Status (19)

Country Link
US (1) US6555576B1 (no)
EP (1) EP1156800A4 (no)
JP (1) JP2002538115A (no)
KR (1) KR20010102460A (no)
CN (1) CN1350453A (no)
AR (1) AR035987A1 (no)
AU (1) AU3715000A (no)
BR (1) BR0008625A (no)
CA (1) CA2366041A1 (no)
CO (1) CO5150236A1 (no)
CZ (1) CZ20013148A3 (no)
HK (1) HK1043727A1 (no)
HU (1) HUP0200026A3 (no)
IL (1) IL144996A0 (no)
NO (1) NO20014221L (no)
NZ (1) NZ513697A (no)
PL (1) PL352822A1 (no)
TR (1) TR200102515T2 (no)
WO (1) WO2000051599A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY121142A (en) * 1999-02-23 2005-12-30 Smithkline Beecham Corp Controlled release formulation for treating copd
HUP0203682A3 (en) * 1999-10-29 2003-10-28 Smithkline Beecham Plc Method for administering a phosphodiesterase 4 inhibitor
GB0103630D0 (en) 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
CA2458534C (en) 2001-09-14 2011-11-01 Glaxo Group Limited Phenethanolamine derivatives for treatment of respiratory diseases
GB0201677D0 (en) 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
DK1556342T3 (da) 2002-10-28 2008-07-21 Glaxo Group Ltd Phenethanolaminderivat til behandling af respiratoriske sygdomme
GB0303396D0 (en) 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds
JPWO2004087147A1 (ja) * 2003-03-31 2006-06-29 協和醗酵工業株式会社 肺疾患の治療および／または予防剤
GB0317374D0 (en) 2003-07-24 2003-08-27 Glaxo Group Ltd Medicament dispenser
EP1699436A2 (en) * 2003-12-12 2006-09-13 Myogen, Inc. Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
EP1737447A1 (en) * 2004-03-22 2007-01-03 Myogen, Inc. (r)-enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
WO2005092332A1 (en) * 2004-03-22 2005-10-06 Myogen, Inc. (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
EP1776108A1 (en) * 2004-06-23 2007-04-25 Myogen, Inc. Enoximone formulations and their use in the treatment of pde-iii mediated diseases
GB0418278D0 (en) 2004-08-16 2004-09-15 Glaxo Group Ltd Medicament dispenser
PE20061351A1 (es) 2005-03-25 2007-01-14 Glaxo Group Ltd COMPUESTOS 8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA 2,4,8-TRISUSTITUIDOS COMO INHIBIDORES DE LA QUINASA CSBP/RK/p38
GB0515584D0 (en) 2005-07-28 2005-09-07 Glaxo Group Ltd Medicament dispenser
GB0525337D0 (en) * 2005-12-13 2006-01-18 Novartis Ag Organic compounds
GB0622827D0 (en) 2006-11-15 2006-12-27 Glaxo Group Ltd Sheet driver for use in a drug dispenser
US20090209488A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions for the treatment of exercise induced asthma
WO2018094392A1 (en) 2016-11-21 2018-05-24 Lupin Inc. Medicament dispenser
WO2019195711A1 (en) 2018-04-06 2019-10-10 Lupin Inc. Medicament dispenser
WO2020058823A1 (en) 2018-09-17 2020-03-26 Lupin, Inc. Dose indicator assembly for a medicament dispenser
WO2021195353A1 (en) 2020-03-25 2021-09-30 Lupin Inc. Multi-carrier medicament dispensers
US20230270956A1 (en) 2020-07-23 2023-08-31 Lupin Inc. Dose counter assemblies for medicament dispensers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301943A (es) 1992-04-02 1994-08-31 Smithkline Beecham Corp Compuestos.

Also Published As

Publication number Publication date
CO5150236A1 (es) 2002-04-29
KR20010102460A (ko) 2001-11-15
WO2000051599A1 (en) 2000-09-08
EP1156800A1 (en) 2001-11-28
TR200102515T2 (tr) 2002-04-22
HK1043727A1 (zh) 2002-09-27
HUP0200026A2 (hu) 2002-05-29
CA2366041A1 (en) 2000-09-08
CZ20013148A3 (cs) 2002-08-14
NO20014221D0 (no) 2001-08-31
HUP0200026A3 (en) 2003-03-28
CN1350453A (zh) 2002-05-22
US6555576B1 (en) 2003-04-29
NZ513697A (en) 2001-09-28
BR0008625A (pt) 2002-02-19
EP1156800A4 (en) 2004-11-24
AR035987A1 (es) 2004-08-04
PL352822A1 (en) 2003-09-08
IL144996A0 (en) 2002-06-30
JP2002538115A (ja) 2002-11-12
AU3715000A (en) 2000-09-21

Similar Documents

Publication Publication Date Title
NO20014221L (no) Fremgangsmåte for behandling av anstrengelses-indusert astma
DE69516866D1 (de) Stereochemische wortmanninderivate
DK1076657T3 (da) Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling
DE69831937D1 (de) Bicyclische protein-farnesyl-transferase inhibitoren
AP1699A (en) New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
EA200001102A1 (ru) Способ синтеза ингибиторов сох-2 (циклооксигеназы-2)
NO996578L (no) Urokinase-inhibitorer
BG101712A (en) Method for cathepsin k inhibition
EA200001129A3 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
EP1405048A4 (en) METHOD AND APPARATUS FOR FOLLOWING A MUSIC SHEET
WO2002030353A3 (en) NF-λB INHIBITORS
ATE250077T1 (de) Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung
AU2002331627A1 (en) Apparatus and method for pre-treatment of wood chips
AU2001260880A1 (en) Pharmaceutical compounds for treating copd
BR9808923B1 (pt) processos para fazer compostos inibidores de ciclooxigenase-2, e, compostos intermediÁrios para fazer inibidores de ciclooxigenase-2.
AU2001268233A1 (en) Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3
NO20014222L (no) Fremgangsmåte for behandling av COPD
NO20015896D0 (no) Fremgangsmåte for å belegge partikler og partikler produsert ved denne
SG94751A1 (en) Method for the production of substrates, magnetron source and sputter-coating chamber
EP1385993B8 (en) Method of detecting and treating tuberous sclerosis complex associated disorders
PL330227A1 (en) Method of obtaining phenylheterocyclic compounds suitable as cox-2 inhibitors
ATE319689T1 (de) Naphthamidin-urokinasinhibitoren
EP0954313A4 (en) METHOD FOR TREATING TUMORS WITH LOW DENSITY LIPOPROTEIN (LDL) NEEDS USING MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN (MTP) INHIBITORS
AU5258701A (en) Method of searching for arteriosclerosis inhibitors and shrinkers
MY133345A (en) Method for treating exercise induced asthma

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application